A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...
Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...
The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback